Sprints

Outcome-focused, 2 part meetings - walk away with deeper insights.

HealthXL Digital Health Sprints allows you to deep dive into a topic over 2 focused sessions with the same group of 8-12 thought leaders
Find your group of peers below:

Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology

Sprint: Virtual Care in Oncology: HCP and Patient Adoption (Part 1)

25th May @ 10:45 AM EDT

Are you struggling with getting HCPs and patients to adopt your digital health solution in oncology? Apply now to join this series of two meetings to discuss this topic further and learn from your peers.

Featuring
Carole Tremonti
Carole Tremonti
VP Clinical Strategy, Project Ronin
Maike Schmitz
Maike Schmitz
Oncology Lead, RoX Health
Featuring
Carole Tremonti
Carole Tremonti
VP Clinical Strategy, Project Ronin
Maike Schmitz
Maike Schmitz
Oncology Lead, RoX Health
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Sprint: Virtual Care for Cardiovascular Diseases: Payment Models & Adoption (Part 2)

7th June @ 10:45AM EDT

What are the best payment models for delivering virtual care to cardiovascular patients? How can we maximize adoption? Join this two-part meeting to share and learn from the experiences of others working in this field.

Featuring
Tim Fonte
Tim Fonte
SVP Upstream Marketing, Heartflow, Inc
Patrick Keenan
Patrick Keenan
Associate Director - Business & Commercial Development, Rx+ Commercial Group at Astellas Pharma
Featuring
Tim Fonte
Tim Fonte
SVP Upstream Marketing, Heartflow, Inc
Patrick Keenan
Patrick Keenan
Associate Director - Business & Commercial Development, Rx+ Commercial Group at Astellas Pharma
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Sprint: Virtual Care for T2-Diabetes and Obesity (Part 2)

3rd March @ 10:45AM EDT

Join the second meeting of this series, Led by Lee Shapiro of 7wire Ventures, as we discuss Virtual Care for T2- Diabetes and Obesity. Our sprint sessions allow you to deep dive into a particular topic and share insights with thought leaders and peers in the industry.

Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Jim Howard
Jim Howard
CEO, Readout Health
Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Jim Howard
Jim Howard
CEO, Readout Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: DTx last mile delivery: HCPs and Patient adoption (Part 2)

3rd February @ 10:45AM EDT

Are you struggling getting HCPs and/or patients to adopt your DTx products? Keep reading, this sprint is for you! Places are limited so apply now to join the second session of this series and discuss with other senior leaders, DTx last mile delivery.

Featuring
Katie Archer
Katie Archer
Director, Health & Welfare Benefits Design, Planning and Analysis at The Hartford
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Featuring
Katie Archer
Katie Archer
Director, Health & Welfare Benefits Design, Planning and Analysis at The Hartford
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: Best routes to market for DTx in the US

7th December @ 10:45AM EDT

Join us in this series of 2 meetings to discuss in detail with other senior leaders the best routes to market for DTx products in the US market. Apply now to be part of the conversation and shares your thoughts on the topic.

Featuring
Eugene Borukhovich
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health
Kyloon Chuah
Kyloon Chuah
Co-Founder & CEO @ Veriteos
Featuring
Eugene Borukhovich
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health
Kyloon Chuah
Kyloon Chuah
Co-Founder & CEO @ Veriteos
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: Prescription DTx - Commercialization Models & Adoption

21st September @ 10:45AM EDT

Join this series of 2 meetings to discuss with other senior leaders Commercialization Models & Adoption in Prescription DTx. Limited spaces available so apply now to secure your place in the conversation.

Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: DTx and RPM for Oncology

29th July @ 9:45AM EDT

This series of 2 meetings to discuss in detail with other thought leaders the best routes to market to get paid for a digital health solution in oncology and the challenges in adoption and last-mile distribution. Limited spaces available to apply now to secure your place in the conversation.

Featuring
David Salmon
David Salmon
Head of Digital Innovation & Capabilities, Global Oncology at AstraZeneca
Hassan Naqvi
Hassan Naqvi
Lead, External Alliances and Digital Partnerships at AstraZeneca
Featuring
David Salmon
David Salmon
Head of Digital Innovation & Capabilities, Global Oncology at AstraZeneca
Hassan Naqvi
Hassan Naqvi
Lead, External Alliances and Digital Partnerships at AstraZeneca
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: DTx for Neurology

27th July @ 9:45AM EDT

This series of 2 meetings discusses in detail with other thought leaders the current state of DTx in neurology, what indications are best suited to such interventions, and commercial opportunities that they present. These interactive sessions are a great opportunity to connect with peers and meet new people.

Featuring
Richie Bavasso
Richie Bavasso
Co-Founder, nQ Medical
Matt Norton
Matt Norton
Vice President of Marketing & Commercial Development at S3 Connected Health
Featuring
Richie Bavasso
Richie Bavasso
Co-Founder, nQ Medical
Matt Norton
Matt Norton
Vice President of Marketing & Commercial Development at S3 Connected Health
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation

Sprint: Digital measures in Clinical Trials

1st July @ 10:30AM EDT

This series of 2 meetings to discuss in detail with other thought leaders the main challenges to successfully include digital measures in clinical trials. Limited seats available so apply now to secure your place in the discussion.


Featuring
Brian Caulfield
Brian Caulfield
Director, Insight Centre for Data Analytics
Graham Jones
Graham Jones
Director of Innovation , Novartis
Featuring
Brian Caulfield
Brian Caulfield
Director, Insight Centre for Data Analytics
Graham Jones
Graham Jones
Director of Innovation , Novartis
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: Digital Women's Health

16th June @ 10:30AM EDT

This series of 2 meetings discusses in detail with other thought leaders the main unmet needs/gaps in Women’s Health and the best routes to market and adoption strategies for Digital Health products in the space.

Featuring
Estefanía 'Nia' Escobar-Kölle
Estefanía 'Nia' Escobar-Kölle
Innovation Manager Life & Health Ventures, SCOR
Caoimhe Vallely-Gilroy
Caoimhe Vallely-Gilroy
Head of Digital Health & Therapeutics at Healthcare Business of Merck
Featuring
Estefanía 'Nia' Escobar-Kölle
Estefanía 'Nia' Escobar-Kölle
Innovation Manager Life & Health Ventures, SCOR
Caoimhe Vallely-Gilroy
Caoimhe Vallely-Gilroy
Head of Digital Health & Therapeutics at Healthcare Business of Merck